NEW YORK ( TheStreet) -- Shares of China-biotics (Nasdaq: CHBT) have taken a tremendous swing upward. The stock is trading at $3.20 as of 3:50 p.m. ET, 21.2% above Friday's closing price of $2.64. Volume is at 140,599, 0.2 times the daily average of 776,600.

China-biotics has a market cap of $76.6 million and is part of the health care sector and drugs industry. Shares are down 87.8% year to date as of the close of trading on Friday.

China-Biotics, Inc. engages in the research, development, production, marketing, and distribution of probiotics products in the People's Republic of China. Its products contain live microbial food supplements, which beneficially affect the host by improving its intestinal microbial balance. The company has a P/E ratio of 2.7, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates China-biotics as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including weak operating cash flow and a generally disappointing performance in the stock itself. You can view the full China-biotics Ratings Report.

See our top % gaining stocks list for other stocks that are soaring today, or get investment ideas from our investment research center.

Interested in other stocks that are soaring? Get free SMS text alerts sent to you when the action happens by texting SOAR to 95370 or select from multiple alert options.